97 related articles for article (PubMed ID: 12385857)
1. Prevalence and determinants of hormone replacement therapy in German women 1984-1995.
Mueller JE; Döring A; Heier M; Löwel H
Maturitas; 2002 Oct; 43(2):95-104. PubMed ID: 12385857
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy in Germany: determinants and possible health-related outcomes. Results of National Health Surveys from 1984 to 1999.
Du Y; Melchert HU; Schäfer-Korting M
Maturitas; 2005; 52(3-4):223-34. PubMed ID: 16040212
[TBL] [Abstract][Full Text] [Related]
3. Use of hormone replacement therapy (HRT) among women aged 45-64 years in the German EPIC-cohorts.
Nagel G; Lahmann PH; Schulz M; Boeing H; Linseisen J
Maturitas; 2007 Apr; 56(4):436-46. PubMed ID: 17194554
[TBL] [Abstract][Full Text] [Related]
4. Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000.
Million Women Study Collaborators
BJOG; 2002 Dec; 109(12):1319-30. PubMed ID: 12504965
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
Moorhead T; Hannaford P; Warskyj M
Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
[TBL] [Abstract][Full Text] [Related]
6. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
Lucas R; Barros H
Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
[TBL] [Abstract][Full Text] [Related]
7. Use of hormone replacement therapy in Italian women aged 50-70 years.
Manzoli L; Di Giovanni P; Del Duca L; De Aloysio D; Festi D; Capodicasa S; Monastra G; Romano F; Staniscia T
Maturitas; 2004 Nov; 49(3):241-51. PubMed ID: 15488353
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy in Norwegian women, 1996-1997.
Bakken K; Eggen AE; Lund E
Maturitas; 2001 Nov; 40(2):131-41. PubMed ID: 11716991
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
10. Prescription of hormone replacement therapy in postmenopausal women with renal failure.
Stehman-Breen CO; Gillen D; Gipson D
Kidney Int; 1999 Dec; 56(6):2243-7. PubMed ID: 10594801
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
Oddens BJ; Boulet MJ
Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
[TBL] [Abstract][Full Text] [Related]
12. Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.
Lambert LJ; Straton JA; Knuiman MW; Bartholomew HC
J Epidemiol Community Health; 2003 Apr; 57(4):294-300. PubMed ID: 12646547
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer incidence and mortality in relationship to hormone replacement therapy use among women participating in the PLCO trial: a post hoc analysis.
Abdel-Rahman O
Int J Clin Oncol; 2020 May; 25(5):885-891. PubMed ID: 31919692
[TBL] [Abstract][Full Text] [Related]
14. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy is associated with a decreased prevalence of peripheral arterial disease in postmenopausal women.
Rockman CB; Maldonado TS; Jacobowitz GR; Adelman MA; Riles TS
Ann Vasc Surg; 2012 Apr; 26(3):411-8. PubMed ID: 22285341
[TBL] [Abstract][Full Text] [Related]
16. The use of complementary and alternative medicine by women transitioning through menopause in Germany: results of a survey of women aged 45-60 years.
Buhling KJ; Daniels BV; Studnitz FS; Eulenburg C; Mueck AO
Complement Ther Med; 2014 Feb; 22(1):94-8. PubMed ID: 24559823
[TBL] [Abstract][Full Text] [Related]
17. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women.
Maddalozzo GF; Widrick JJ; Cardinal BJ; Winters-Stone KM; Hoffman MA; Snow CM
Bone; 2007 May; 40(5):1244-51. PubMed ID: 17291843
[TBL] [Abstract][Full Text] [Related]
18. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and mammographic screening outcomes in Western Australia.
Crouchley K; Wylie E; Khong E
J Med Screen; 2006; 13(2):93-7. PubMed ID: 16792833
[TBL] [Abstract][Full Text] [Related]
20. The use and discontinuation of hormone replacement therapy in women in South China.
Chu K; Song Y; Chatooah ND; Weng Q; Ying Q; Ma L; Qu F; Zhou J
Climacteric; 2018 Feb; 21(1):47-52. PubMed ID: 29166793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
